[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3596080T3 - Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater - Google Patents

Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater Download PDF

Info

Publication number
DK3596080T3
DK3596080T3 DK18713016.6T DK18713016T DK3596080T3 DK 3596080 T3 DK3596080 T3 DK 3596080T3 DK 18713016 T DK18713016 T DK 18713016T DK 3596080 T3 DK3596080 T3 DK 3596080T3
Authority
DK
Denmark
Prior art keywords
pyrimidine derivatives
pharmacological active
substituted pyrazolo
active alicyclic
alicyclic
Prior art date
Application number
DK18713016.6T
Other languages
English (en)
Inventor
István Borza
János Éles
Zsuzsa Hadady
Viktor Román
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK3596080T3 publication Critical patent/DK3596080T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK18713016.6T 2017-03-13 2018-03-12 Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater DK3596080T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1700108A HU231058B1 (hu) 2017-03-13 2017-03-13 Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
PCT/IB2018/051599 WO2018167630A1 (en) 2017-03-13 2018-03-12 PHARMACOLOGICALLY ACTIVE ALICYCLIC-SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
DK3596080T3 true DK3596080T3 (da) 2021-11-15

Family

ID=89992389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18713016.6T DK3596080T3 (da) 2017-03-13 2018-03-12 Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater

Country Status (32)

Country Link
US (1) US11026946B2 (da)
EP (1) EP3596080B1 (da)
JP (1) JP7153662B2 (da)
KR (1) KR20190127779A (da)
CN (1) CN110431142A (da)
AR (1) AR111176A1 (da)
AU (1) AU2018235266B2 (da)
BR (1) BR112019018843A2 (da)
CA (1) CA3056185A1 (da)
CL (1) CL2019002601A1 (da)
CO (1) CO2019010120A2 (da)
CY (1) CY1124708T1 (da)
DK (1) DK3596080T3 (da)
EA (1) EA038756B1 (da)
EC (1) ECSP19072975A (da)
ES (1) ES2893824T3 (da)
GE (1) GEP20217256B (da)
HR (1) HRP20211850T1 (da)
HU (2) HU231058B1 (da)
IL (1) IL268923A (da)
LT (1) LT3596080T (da)
MX (1) MX2019011000A (da)
MY (1) MY195262A (da)
PE (1) PE20191646A1 (da)
PH (1) PH12019501968A1 (da)
PL (1) PL3596080T3 (da)
PT (1) PT3596080T (da)
RS (1) RS62533B1 (da)
SG (1) SG11201907864YA (da)
SI (1) SI3596080T1 (da)
UA (1) UA124783C2 (da)
WO (1) WO2018167630A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
TW202202495A (zh) 2020-03-26 2022-01-16 匈牙利商羅特格登公司 作為ｇａｍｍａ－胺基丁酸Ａ受體次單元ａｌｐｈａ ５受體調節劑之㖠啶及吡啶并〔３，４－ｃ〕嗒𠯤衍生物
TW202220992A (zh) 2020-08-05 2022-06-01 匈牙利商羅特格登公司 具藥理活性之經雜環取代的吡唑并〔１，５－ａ〕嘧啶衍生物
HUP2100338A1 (hu) 2021-09-29 2023-04-28 Richter Gedeon Nyrt GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0508310A (pt) 2004-03-02 2007-07-24 Hoffmann La Roche derivados de 4-(sulfanil-pirimidin-4-ilmetil)-morfolina e compostos relacionados como ligandos do receptor gaba, para o tratamento de ansiedade, depressão e epilepsia
GB0512844D0 (en) 2005-06-23 2005-08-03 Novartis Ag Organic compounds
KR100753017B1 (ko) * 2006-05-25 2007-08-30 한국화학연구원 7-(3,4-디알콕시페닐)-피라졸로[1,5-ａ]피리미딘 화합물을포함하는 관절염, 아토피 피부염, 백혈병을 포함한 암 및알쯔하이머, 우울증 또는 기억력 감소 등의 뇌질환의 치료및 예방을 위한 약제학적 조성물
US8461163B2 (en) 2008-03-31 2013-06-11 Takeda Pharmaceutical Company Limited Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1
TWI648281B (zh) 2013-10-17 2019-01-21 日商安斯泰來製藥股份有限公司 含硫二環式化合物
WO2016169995A1 (en) 2015-04-20 2016-10-27 AbbVie Deutschland GmbH & Co. KG Substituted pyrazolopyrimidines and method of use
JP2018199623A (ja) * 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok

Also Published As

Publication number Publication date
AU2018235266B2 (en) 2021-09-30
HUP1700108A2 (en) 2018-09-28
LT3596080T (lt) 2021-11-25
PT3596080T (pt) 2021-10-22
JP7153662B2 (ja) 2022-10-14
RS62533B1 (sr) 2021-11-30
US20200129515A1 (en) 2020-04-30
GEP20217256B (en) 2021-05-25
PE20191646A1 (es) 2019-11-07
SG11201907864YA (en) 2019-09-27
CY1124708T1 (el) 2022-07-22
HUE056562T2 (hu) 2022-02-28
ES2893824T3 (es) 2022-02-10
WO2018167630A1 (en) 2018-09-20
CA3056185A1 (en) 2018-09-20
EP3596080A1 (en) 2020-01-22
IL268923A (en) 2019-10-31
EA201992127A1 (ru) 2020-02-06
KR20190127779A (ko) 2019-11-13
BR112019018843A2 (pt) 2020-04-14
US11026946B2 (en) 2021-06-08
CO2019010120A2 (es) 2019-10-09
HU231058B1 (hu) 2020-04-28
PH12019501968A1 (en) 2020-06-29
EP3596080B1 (en) 2021-09-01
SI3596080T1 (sl) 2022-01-31
PL3596080T3 (pl) 2022-01-31
EA038756B1 (ru) 2021-10-14
CN110431142A (zh) 2019-11-08
HRP20211850T1 (hr) 2022-03-04
AR111176A1 (es) 2019-06-12
ECSP19072975A (es) 2019-11-30
JP2020510041A (ja) 2020-04-02
MY195262A (en) 2023-01-11
MX2019011000A (es) 2019-10-17
AU2018235266A1 (en) 2019-10-17
UA124783C2 (uk) 2021-11-17
CL2019002601A1 (es) 2020-01-24

Similar Documents

Publication Publication Date Title
HK1258157A1 (zh) 作為jak抑制劑的吡唑並[1，5-a]吡嗪-4-基衍生物
IL266305B (en) History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors
DK3478682T3 (da) [1,2,4]triazolo[1,5-a]pyridinylsubstituerede indolforbindelser
HRP20190361T1 (hr) Derivati triazolo[4,5-d]pirimidina kao antagonisti cb2 receptora
EP3268000A4 (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
IL254224A0 (en) 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors
IL268923A (en) History of alicyclic-converted pyrazolo[5,1-a]pyrimidine pharmacological activity
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
BR112016011072A8 (pt) 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-hexahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-ona, sais destes e métodos de uso.
HUE056561T2 (hu) Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
IL290419A (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
IL272988A (en) Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors
TH1601001194A (th) อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่